Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01695993 · ClinicalTrials.gov registry record · NA

Alternative Approaches for Nausea Control

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
242
Enrollment target

NCT01695993 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 242 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01695993, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
242 participants
Enrollment target

Study Summary

216 Chemotherapy-naïve, female breast cancer patients about to begin chemotherapy and who expect to have nausea, will be entered. Participants will be randomized to one of three study arms: Arm 1: control; Arm 2: Expectancy-neutral handout + Expectancy-neutral MP3+ acupressure bands; Arm 3: Expectancy-enhancing handout + Expectancy-enhancing MP3 + acupressure bands. Hypothesis: Acupressure bands provided with the relaxation MP3 will be effective in controlling chemotherapy-induced nausea

Interventions

  • DEVICE Acupressure bands
  • OTHER Expectancy-neutral handout
  • BEHAVIORAL Expectancy-neutral MP3
  • OTHER Expectancy-enhancing handout
  • BEHAVIORAL Expectancy-enhancing MP3

Trial Details

FieldValue
Enrollment Target 242 participants
Start Date 2012-11
Est. Completion 2017-05-16
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01695993

The ClinicalTrials.gov registry entry for NCT01695993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Acupressure bands is the first listed.

NCT01695993 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01695993 about?

NCT01695993 is a clinical study titled "Alternative Approaches for Nausea Control". 216 Chemotherapy-naïve, female breast cancer patients about to begin chemotherapy and who expect to have nausea, will be entered. Participants will be randomized to one of three study arms: Arm 1: control; Arm 2: Expectancy-neutral handout + Expectancy-neutral MP3+ acupressure bands; Arm 3: Expectan...

What is the current status of trial NCT01695993?

This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2012-11. Estimated completion is 2017-05-16.

What interventions are being tested in trial NCT01695993?

The interventions under investigation include: Acupressure bands (DEVICE), Expectancy-neutral handout (OTHER), Expectancy-neutral MP3 (BEHAVIORAL), Expectancy-enhancing handout (OTHER), Expectancy-enhancing MP3 (BEHAVIORAL).

Who is sponsoring clinical trial NCT01695993?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.